Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: Implications for the nutritional carcinostatic activity of selenoamino acids

Biochemical Pharmacology

Volumn 67, Issue 3, 2004, Pages 547-554

  Spallholz, Julian E ^a   Palace, Vince P ^b   Reid, Ted W ^c  

^a TEXAS TECH UNIVERSITY   (United States)

^b FISHERIES AND OCEANS CANADA   (Canada)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis; Cancer; Methylselenol; Se methylselenocysteine; Selenium; Selenomethionine; Superoxide

Indexed keywords

ASCORBIC ACID; DEXTRO SELENOETHIONINE; GLUTATHIONE; METHIONINE; METHIONINE GAMMA LYASE; METHYLSELENOL; RADICAL; RECOMBINANT ENZYME; SE METHYLSELENOCYSTEINE; SELENIUM; SELENIUM DERIVATIVE; SELENOAMINO ACID; SELENOMETHIONINE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CATALYSIS; CELL CYCLE; CHEMOLUMINESCENCE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SUBSTRATE; IN VITRO STUDY; IN VIVO STUDY; NUTRITION; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 1242263520     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.09.004     Document Type: Article

References (45)

1. Raymond M.P. The importance of selenium to human health. Lancet. 356:2000;233-241.
2. Clark LC, Combs Jr GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Kongrad A, Lesher Jr JL, Park HK, Sanders Jr BB, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63.
3. Combs G.F. Jr. Chemopreventive agents: selenium. Pharmacol. Ther. 79:1998;179-192.
4. Combs G.F. Jr. Chemopreventive mechanisms of selenium. Med. Klin. 94:1999;18-24.
5. Spallholz JE. Selenium and the prevention of cancer. Part 1. Bull Selenium-Tellurium Dev Assoc; 2001. Available at: www.selenomethionine.com .
6. Ip C. Lessons from basic research in selenium and cancer prevention. J. Nutr. 128:1998;1845-1854.
7. Whanger P.D. Selenocompounds in plants and animals and their biological significance. J. Am. Coll. Nutr. 21:2002;223-232.
8. Ip C., Thompson H.J., Zhu Z., Ganther H.E. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 60:2000;2882-2886.
9. Lanfear J., Flrming J., Wu L., Webster G., Harrison P.R. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis. 15:1994;1387-1392.
10. Lu J., Kaeck M., Jiang C., Wilson A.C., Thompson H.J. Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem. Pharmacol. 47:1994;1531-1535.
11. el-Bayoumy K., Upadhyaya P., Chae Y.H., Sohn O.S., Rao C.V., Fiala E., Readdy B.S. Chemoprevention of cancer by organoselenium compounds. J. Cell Biochem. Suppl. 22:1995;92-100.
12. Redman C., Xu M.J., Peng Y.M., Scott J.A., Payne C., Clark L.C., Nelson M.A. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis. 18:1997;1195-2002.
13. Zhu Z., Kimura M., Itokawa Y., Aoki T., Takahasi J.A., Nakatsu S., Oda Y., Kikuchi H. Apoptosis induced by selenium in human glioma cell lines. Biol. Trace Elem. Res. 54:1996;123-134.
14. 3. Biol. Trace Elem. Res. 85:2002;241-254.
15. Dong Y., Ganther H.E., Stewart C., Ip C. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res. 62:2002;708-714.
16. Zhong W., Oberley T.D. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res. 61:2001;7171-7178.
17. Hiraoka K., Komiya S., Hamada T., Zenmyo M., Inoue A. Osteosarcoma cell apoptosis induced by selenium. J. Orthop. Res. 19:2001;809-814.
18. Jung U., Zheng X., Yoon S.O., Chung A.S. Se-methyleselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Free Radic. Biol. Med. 31:2001;479-489.
19. Lu J. Apoptosis and angiogenesis in cancer prevention by selenium. Adv. Exp. Med. Biol. 492:2001;131-145.
20. Ip C., Dong Y. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer Res. 21:2001;863-867.
21. Wei Y., Cao X., Ou Y., Iu J., Xing C., Zheng R. SeO(2) induces apoptosis with down-regulation of Bel-2 and up-regulation of P53 expression in both immortal human hepatic cell line and hepatoma cell line. Mutat. Res. 490:2001;113-121.
22. Stewart M., Neldner K., Spallholz J., Pence B. Selenite, selenocystamine, and selenomethionine have disparate abilities to impose oxidative stress and induce apoptosis in mouse keratinocytes. Free Radic. Biol. Med. 26:1999;42-48.
23. Spallholz J. On the nature of selenium toxicity and carcinostatic activity. 17:1994;45-64.
24. Spallholz J.E.D. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed. Environ. Sci. 10:1997;260-270.
25. Seko Y, Saito Y, Kitahara J, Imura N. Active oxygen generation by the reaction of selenite with reduced glutathione in vitro. In: Wendel A, editor. Selenium in biology and medicine. Berlin: Springer-Verlag; 1989. p. 70-83.
26. Wang Z., Jeang C., Lu J. Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol. Mol. Carcinog. 34:2002;113-120.
27. Spallholz J.E., Shriver B.J., Reid T.W. Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine. Nutr Cancer. 40:2001;34-41.
28. Zhu Z., Kimura M., Tonkawa Y., Aoki T., Takahashi J.A., Naiads S., Ode Y., Kikuchi H. Apoptosis induced by selenium in human glioma cell lines. Biol. Trace. Elem. Res. 54:1996;123-134.
29. Shen H.M., Yang C.F., Ong C.N. Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2cells. Int. J. Cancer. 81:1999;820-828.
30. Shen H.M., Ding W.X., Ong C.N. Intracellular glutathione is a cofactor in methylseleninic acid-induced apoptotic cell death of human hepatoma HEPG(2) cells. Free Radic. Biol. Med. 33:2002;552-561.
31. Lee S.K., Heo Y.H., Steele V.E., Pezzuto J.M. Induction of apoptosis by 1,4-phenylene-bis(methylene)selenocyanate in cultured human colon cancer cells. Anticancer Res. 22:2002;97-102.
32. Baines A.T., Holbec H., Basye J.L., Thorne P., Bhattachayya A.K., Spallholz J.E., Shriver B., Clark L.C., Earnest D.L., Nelson M.A. Chemopreventative effects of dietary selenomethionine on polyamines and the initiation/promotional stages of azoxymethane-induced rat colon carcinogenesis. Cancer Lett. 160:2000;193-198.
33. Jiang C., Jiang W., Ip C., Ganther H., Lu J. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol. Carcinog. 26:1999;213-225.
34. Rooseboom M. Novel organoselenium prodrugs: mechanisms of bioactivation, kidney selectivity and chemoprotective properties of selenocysteiene se-conjugates. Dissertation. Virije Universiteit, Amsterdam; 2002. 325 pp.
35. Roosboom M., Vermeulen N.P.E., Commandeur J.N.M. Enzymatic pathways of B-elimination of chemopreventive selenocysteine Se-conjugates. Methods Enzymol. 348:2002;191-200.
36. Rooseboom M., Vermeulen N.P., van Hemert N., Commandeur J.N. Bioactivation of chemopreventive selenocysteine Se- conjugates and related amino acids by amino acid oxidases novel route of metabolism of selenoamino acids. Chem. Res. Toxicol. 14:2001;996-1005.
37. Spallholz J.E., Hoffman D.J. Selenium toxicity: cause and effects in aquatic birds. Aquat. Toxicol. 57:2002;27-37.
38. Holm J, Palace VP, Kautier RE, Evans CL, Baron C, Podemski P, Siwik G, Sterling G. An assessment of the development and survival of wild rainbow trout (O. mykiss) and brook trout (S. fontinalis) exposed to elevated selenium in an area of active coal mining. In: Proceedings of the 26th Annual Larval Fish Conference. Bergen, Norway; 2002 [abstracts].
39. Lemly A.D. Symptoms and implications of selenium toxicity in fish: the Belews Lake case example. Aquat. Toxicol. 57:2002;39-49.
40. Hoffman D.J. Role of selenium toxicity and oxidative stress in aquatic birds. Aquat. Toxicol. 57:2002;11-26.
41. Miki K., Xu M., Gupta A., Ba Y., Tan Y., Al-Refaie W., Bouvet M., Makuuchi M., Moossa A.R., Hoffman R.M. Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate. Cancer Res. 61:2001;6805-6810.
42. Yamamoto N., Gupta A., Xu M., Miki K., Tsujimoto Y., Tsuchiya H., Tomita K., Moossa A.R., Hoffman R.M. Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells. Cancer Gene Ther. 10:2003;445-450.
43. May S.W. Selenium-based pharmacological agents: an update. Exp. Opin. Invest. Drugs. 11:2002;1201-1269.
44. Spallholz JE, Reid T, Boylan LM, Shriver B. Selenium free radical chemistry: applications for pharmaceuticals. In: Proceedings of the 6th International Symposium on Selenium and Tellurium; 1998. p. 47-56.
45. Chaudiere J., Courtin O., Leclaire J. Glutathione oxidase activity of selenocystamine: a mechanistic study. Arch. Biochem. Biophys. 296:1992;328-336.